News


October 08, 2014:Kane Biotech Appoints Mark Nawacki to the Board of Directors Read more...

October 06, 2014:Kane Biotech Announces Private Placement Offering Read more...

September 23, 2014:Kane Biotech Provides Business and Patent Update Read more...

July 22, 2014:Health Canada approves DispersinB® for Human Use Read more...

June 26, 2014:Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest Read more...

Products


DispersinB® is the company's trademark for the wound care market, which contains a portfolio of wound care solutions. Read more...

Aledex® is the company's trademark for the medical device coating market, which is a device coating technology. Read more...

StrixNB™ is the company's trademark for the oral care market, which contains a portfolio of oral care products. Read more...

KBI Antibacterial Disinfectant is the company's product line for the surface disinfectants market, which are antibiofilm-antimicrobial surface disinfectant solutions. Read more...

What's New


StrixNB Logo

Click here to learn more about StrixNB™ Pet Oral Care Water Additive


Read more about Kane's latest product - KBI Antibacterial Disinfectant (KBI).KBI contains a unique, patented, antimicrobial-antibiofilm combination comprised of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP).

White Papers


KBI Antibacterial Hard Surface Disinfectant